Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SQL | SeqLL Inc.

Index- P/E- EPS (ttm)-15.93 Insider Own22.20% Shs Outstand0.35M Perf Week10.17%
Market Cap5.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.18M Perf Month23.99%
Income-5.30M PEG- EPS next Q- Inst Own0.20% Short Float / Ratio0.66% / 0.02 Perf Quarter-9.05%
Sales0.00M P/S- EPS this Y32.90% Inst Trans- Short Interest0.00M Perf Half Y3.50%
Book/sh8.39 P/B1.82 EPS next Y- ROA-64.20% Target Price- Perf Year-55.13%
Cash/sh13.83 P/C1.11 EPS next 5Y- ROE-124.10% 52W Range9.21 - 96.00 Perf YTD31.41%
Dividend- P/FCF- EPS past 5Y-11.70% ROI- 52W High-84.08% Beta1.23
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin- 52W Low65.94% ATR3.06
Employees7 Current Ratio5.00 Sales Q/Q- Oper. Margin- RSI (14)51.64 Volatility17.47% 27.23%
OptionableNo Debt/Eq0.55 EPS Q/Q-20.50% Profit Margin- Rel Volume0.89 Prev Close14.37
ShortableYes LT Debt/Eq0.52 EarningsMay 09 BMO Payout- Avg Volume70.43K Price15.28
Recom2.00 SMA201.24% SMA502.32% SMA200-14.94% Volume65,874 Change6.33%
Sep-15-23 05:24PM
Aug-30-23 01:00PM
Jun-27-23 09:24AM
May-30-23 08:30AM
May-09-23 08:30AM
08:30AM Loading…
Mar-17-23 08:30AM
Feb-22-23 06:00AM
Feb-15-23 04:00PM
Feb-13-23 08:30AM
Feb-10-23 09:21AM
Feb-07-23 07:30AM
Dec-22-22 04:00PM
Dec-13-22 09:25AM
Nov-11-22 06:07AM
Nov-09-22 10:08PM
11:56AM Loading…
Sep-13-22 11:56AM
Sep-12-22 08:00AM
Sep-06-22 08:01AM
Jun-24-22 04:05PM
Jun-13-22 08:00AM
May-13-22 08:00AM
Mar-30-22 05:06PM
Mar-24-22 04:05PM
Mar-21-22 04:15PM
Sep-29-21 06:04PM
Sep-27-21 08:00AM
Sep-23-21 02:49PM
Sep-10-21 12:19PM
Aug-31-21 03:17PM
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miscoll Douglas PatrickDirectorDec 19Buy0.331,500495103,736Dec 20 12:36 PM
Miscoll Douglas PatrickDirectorDec 16Buy0.351,500525103,736Dec 20 12:36 PM
JONES DANIEL ROBERTChief Executive OfficerDec 09Buy0.395,7332,2362,565,733Dec 13 03:36 PM
Miscoll Douglas PatrickDirectorSep 27Buy0.771,000774100,736Sep 28 11:05 AM
JONES DANIEL ROBERTChief Executive OfficerSep 26Buy0.795,0003,9472,560,000Sep 28 04:09 PM
Miscoll Douglas PatrickDirectorSep 26Buy0.75850638100,736Sep 28 11:05 AM
Miscoll Douglas PatrickDirectorSep 23Buy0.7615011498,886Sep 26 05:40 PM
Miscoll Douglas PatrickDirectorSep 22Buy0.792,4001,89698,886Sep 26 05:40 PM